Advancing Novel Biotherapeutics Since 1995®
At Dyax Corp., our patients are at the center of everything we do.
Harnessing Dyax phage display technology through partnerships for therapeutic discovery.
Dyax combines a strong foundation in HAE patient care with a commitment to product development in the angioedema field.
Please see Full Prescribing Information, including Boxed Warning and Medication Guide on KALBITOR.com.
rapid and robust research tool for generating highly specific potent binders to challenging therapeutic targets.